Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Guangzhou Henovcom Bioscience discovers autotaxin inhibitors

June 3, 2022

Hongyun Biotech presents new MAP4K1 inhibitors

June 3, 2022

New Rho kinase 2 inhibitors identified at Medshine Discovery

June 3, 2022

Scorpion Therapeutics patents EGFR and/or HER2 inhibitors

June 2, 2022

New Ret inhibitors discovered at Lilly

June 2, 2022

Mirati Therapeutics, Array BioPharma present KRAS Gly12Asp inhibitors

June 2, 2022

Kronos Bio synthesizes new PROTAC CDK9 degradation inducers

June 2, 2022

New MAP4K 1inhibitors identified at Merck & Co.

June 2, 2022

Betta Pharmaceuticals describes histone acetyltransferase KAT3B inhibitors

June 1, 2022

Zydus Lifesciences patents bacterial dihydrofolate reductase inhibitors

June 1, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...